Status:
COMPLETED
MRI Imaging or CT Abdomen as Standard Work-up Before Treatment Planning for Rectal Cancer?
Lead Sponsor:
Sahlgrenska University Hospital
Conditions:
Rectal Cancer
Liver Metastases
Eligibility:
All Genders
Brief Summary
Rectal cancer is a common diagnosis. The prognosis after treatment has improved over the last decades, partly due to neoadjuvant radio(chemo)therapy, but also due to improved surgical technique (TME) ...
Detailed Description
Background: Rectal cancer is a common diagnosis in both men and women, more commonly occurring in men (60%) than women (40%). In Sweden some 2000 cases are diagnosed each year. The prognosis after tr...
Eligibility Criteria
Inclusion
- All patients in the Swedish Colo- Rectal Cancer Registry (SCRCR) and treated for rectal cancer at Sahlgrenska University Hospital and Norra Älvsborg Hospital 2013-2015.
Exclusion
- None
Key Trial Info
Start Date :
March 15 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT03463616
Start Date
March 15 2018
End Date
December 31 2020
Last Update
April 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sahlgrenska university hospital
Gothenburg, Sweden, SE 416 85